2902649-99-2
2902649-99-2
Chemical Structure
Deutaleglitazar
Synonym(s): Aleglitazar-d2; R1439-d2; RO0728804-d2
- CAS No.: 2902649-99-2
- Formula:C24H21D2NO5S
- Molecular Weight:439.52
IUPAC Name: (S)-2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy-1,1-d2)benzo[b]thiophen-7-yl)propanoic acid
InChIKey: DAYKLWSKQJBGCS-UUPVCFDWSA-N
SMILES: CC1=C(CC([2H])([2H])OC2=CC=C(C[C@@H](C(O)=O)OC)C3=C2C=CS3)N=C(C4=CC=CC=C4)O1
Biological Activity: Deutaleglitazar (Aleglitazar-d2) is a agonist of dual peroxisome proliferatory activating receptor (PPARα and PPARγ)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Deutaleglitazar | Deutaleglitazar (Aleglitazar-d2) is a agonist of dual peroxisome proliferatory activating receptor (PPARα and PPARγ). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Aleglitazar | 99.74% | Aleglitazar (R1439) is a potent dual PPARα/γ agonist, with IC50s of 38 nM and 19 nM for human PPARa and PPARγ, respectively. Aleglitazar can be used for the research of type II diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
